The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials

The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials

Abstract Background The low-grade chronic inflammation in diabetes plays an important role in development of cardiovascular and renal complications. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are recognized as protective agents for cardio-renal complications. Interleukin-6 (IL-6) is positive...

Full description

Bibliographic Details
Main Authors: Sepehr Gohari, Faramarz Ismail-Beigi, Mahsa Mahjani, Saeed Ghobadi, Alireza Jafari, Hassan Ahangar, Sheida Gohari
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Endocrine Disorders
Subjects:
SGLT2 inhibitors
Interleukin-6
Diabetes mellitus
Inflammation
Cardiorenal protection
Randomized controlled trial
Online Access:https://doi.org/10.1186/s12902-023-01512-1

Internet

https://doi.org/10.1186/s12902-023-01512-1

Similar Items